These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 1937329)

  • 1. [Effect of omega-3-fatty acids on lipoprotein metabolism. Different effects in various phenotypes].
    Singer P; Hüve J
    Fortschr Med; 1991 Aug; 109(24):476-9. PubMed ID: 1937329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of a clofibrate-inositol nicotinate combination on lipids and lipoproteins in primary hyperlipoproteinemia of types IIa, IV and V].
    Hutt V; Wechsler JG; Klör HU; Ditschuneit H
    Arzneimittelforschung; 1983; 33(5):776-9. PubMed ID: 6683558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute lipidemic effect of calcium heparin in normolipemic and hyperlipemic subjects.
    Ferlito S; Ricceri M; Ossino AM
    Int Angiol; 1989; 8(3):140-4. PubMed ID: 2592796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Dyslipidemic patients with coronary cardiopathy. Effect of different doses of OMEGA-3 fatty acids on serum lipids and lipoproteins].
    Arteaga A; Villanueva CL; Skorin C; Guasch V; Solís de Ovando F; Velasco N; Acosta AM; Leighton F
    Rev Med Chil; 1993 Jun; 121(6):618-25. PubMed ID: 8278696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effects of avocado on the level of blood lipids in patients with phenotype II and IV dyslipidemias].
    Carranza J; Alvizouri M; Alvarado MR; Chávez F; Gómez M; Herrera JE
    Arch Inst Cardiol Mex; 1995; 65(4):342-8. PubMed ID: 8561655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Composition of VLDL, LDL and HDL lipoprotein fractions in type IIa, IIb, III, IV, and V hyperlipemia patients in comparison with healthy individuals].
    Hutt V; Klör HU; Wechsler JG; Ditschuneit H
    J Clin Chem Clin Biochem; 1984 Feb; 22(2):141-6. PubMed ID: 6716054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of fish oils on plasma lipid risk factors and esterified fatty acids in primary hyperlipoproteinemia].
    Zák A; Zeman M; Tvrzická E
    Sb Lek; 1997; 98(3):213-24. PubMed ID: 9601814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of low dose omega-3-fatty acids on blood pressure, blood lipids and blood fluidity in patients with hyperlipoproteinemia].
    Staedt U; Kirschstein W; Simianer S; Kuhn C; Aufenanger J; Holm E
    Vasa Suppl; 1989; 27():253-4. PubMed ID: 2623506
    [No Abstract]   [Full Text] [Related]  

  • 9. Changes in the concentration and composition of lipids and lipoproteins in primary hyperlipoproteinemia during treatment with bezafibrate.
    Hutt V; Wechsler JG; Klör HU; Ditschuneit H
    Arzneimittelforschung; 1983; 33(8):1185-90. PubMed ID: 6685498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The therapeutic efficacy of bezafibrate in hyperlipoproteinemias of various types].
    Noseda G; Fragiacomo C; Weidmann P; Bachmann C
    Schweiz Med Wochenschr; 1980 Dec; 110(49):1875-7. PubMed ID: 7455660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of a new fish oil concentrate on plasma lipids and lipoproteins in patients with hypertriglyceridaemia.
    Mackness MI; Bhatnagar D; Durrington PN; Prais H; Haynes B; Morgan J; Borthwick L
    Eur J Clin Nutr; 1994 Dec; 48(12):859-65. PubMed ID: 7889894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lowering effect of fenofibrate (procetofene) on lipoproteins in different types of hyperlipoproteinemias.
    Canzler H; Bojanovski D
    Artery; 1980; 8(2):171-8. PubMed ID: 7458684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gemfibrozil therapy in primary type II hyperlipoproteinemia: effects on lipids, lipoproteins and apolipoproteins.
    Lupien PJ; Brun D; Gagné C; Moorjani S; Bielman P; Julien P
    Can J Cardiol; 1991; 7(1):27-33. PubMed ID: 2025787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in lipids and lipoproteins in patients with hyperlipidemia type IIb, IV and V treated with different lipid lowering drugs.
    Hutt V; Wechsler JG; Klör HU; Ditschuneit H
    Artery; 1980; 8(2):113-9. PubMed ID: 7458676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversible increase of the apo CII/apo CIII-1 ratio in the very low density lipoproteins after procetofen treatment in hypertriglyceridemic patients.
    Franceschini G; Sirtori M; Gianfranceschi G; Frosi T; Montanari G; Sirtori CR
    Artery; 1985; 12(6):363-81. PubMed ID: 4051756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of n-3 fatty acids on lipids and haemostasis in patients with type IIa and type IV hyperlipidaemia.
    Schmidt EB; Ernst E; Varming K; Pedersen JO; Dyerberg J
    Thromb Haemost; 1989 Sep; 62(2):797-801. PubMed ID: 2814927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Lipids, lipoproteins, arterial accidents and oral contraceptives].
    Bakir R; Hilliquin P
    Contracept Fertil Sex (Paris); 1986 Jan; 14(1):81-7. PubMed ID: 12341243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in serum and lipoprotein lipids, and apolipoprotein B and A-I, in patients with different types of primary hyperlipoproteinaemia treated with gemfibrozil.
    Sommariva D; Branchi A; Pini C; Scandiani L; Orlandi S; Fasoli A
    Int J Clin Pharmacol Res; 1988; 8(5):383-92. PubMed ID: 3068163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of slow-release bezafibrate on serum lipids, lipoproteins, apolipoproteins, and postheparin lipolytic activities in patients with type IV and type V hypertriglyceridemia.
    Saku K; Sasaki J; Arakawa K
    Clin Ther; 1989; 11(3):331-40. PubMed ID: 2743372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Dietary treatment of hyperlipoproteinemia].
    Widhalm K
    Wien Med Wochenschr; 1990 Feb; 140(4):88-93. PubMed ID: 2183475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.